ISRCTN22114173已完成未知
Highly Active Antiretroviral Treatment (HAART) of Human Immunodeficiency Virus (HIV)-infection in a town in Cameroon: randomised controlled study to suggest which treatment starting point is most beneficial for the patients
Institute of Community Medicine, University of Tromsø (Norway)0 个研究点目标入组 100 人开始时间: 2007年7月6日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Treatment naive Human Immunodeficiency Virus (HIV)-infected individuals
- •2. 16 years of age or older
- •3. CD4 count between 450 and 250 cells/mm^3
排除标准
- •1. If patient fulfils current indications for immediate treatment: CD4 less than 250 cells/mm^3 or WHO clinical stage 3 or 4
- •2. If CD4 is currently greater than 450 cells/mm^3 . This is because patient will probably not start Anti-Retroviral Therapy (ART) during the first year to come
研究者
相似试验
已完成
不适用
Highly active anti-retroviral therapy including nevirapine once daily versus twice daily after at least 12 weeks of nevirapine twice daily. A randomized, open, multicentre trial.ISRCTN81305260Institute of Biomedical Investigations of Bellvitge (Institut d'Investigació Biomèdica de Bellvitge) (IDIBELL) (Spain)308
已完成
不适用
Impact of highly active anti-retroviral therapy (HAART) during pregnancy and breastfeeding on mother-to-child transmission (MTCT) and mother's healthHuman immunodeficiency virus (HIV)/acquired immune deficiency syndrome (AIDS)Infections and InfestationsHuman immunodeficiency virus (HIV)ISRCTN71468401World Health Organization (WHO) (Switzerland)2,400
已完成
不适用
Highly Active Antiretroviral Therapy and Cardiovascular Risk factor profiles of HIV-infected Subjects in Nigeria: a cross-sectional studyHypertensionJPRN-UMIN000027983niversity of Warwick Benue State University Teaching Hospital400
已完成
不适用
Directly Observed antiretroviral Therapy for people living with Human Immunodeficiency Virus (HIV) and Acquired ImmunDeficiency Syndrome (AIDS): a randomised controlled trialISRCTN48682427Ministry of Health (Brazil)
招募中
不适用
antiretroviral therapy regimen intensified with maraviroc during early HIV-1 infectioHIV-1 infectionJPRN-UMIN000017975ational Hospital Organization Osaka National Hospital30